Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegowina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Keeling Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia Hrvatska
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands Malvinas
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Jamaica
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint LUCIA
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zambia
Zimbabwe
Print Edition
E-Newsletters & Communications
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.
Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe
Home
Issues
2019
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ESMO 2018
ESMO 2018 Wrap-Up
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines
Audrey Andrews
Authored Items
Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy-Induced Neutropenia
Audrey Andrews
TOP - August 2018, Vol 11, No 2
in
Side-Effects Management
Suboptimal Dosing of Filgrastim is Acceptable for Treatment of Chemotherapy-Induced Neutropenia
Audrey Andrews
TON - May 2018, Vol 11, No 2
in
Side-Effects Management
Project Aims to Prevent Future Infusion-Related Reactions
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
Pharmacy-Led Intervention Improved Tyrosine Kinase Inhibitor Adherence and Monitoring
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
Noncompliance with Granulocyte Colony-Stimulating Factor Guidelines Has Consequences
Audrey Andrews
TOP - May 2017, Vol 10, No 2
in
NCCN News
New Survey Reveals How Pharmacies Manage Verification Processes
Audrey Andrews
TOP - November 2016, Vol 9, No 4
in
Best Practices
Dose Modifications of Lenalidomide Lead to Good Outcomes in Myelodysplastic Syndrome
Audrey Andrews
TOP - November 2016, Vol 9, No 4
in
Hematologic Cancers
Palliative Care Specialists Want More Involvement
Audrey Andrews
TON July 2016 Vol 9 No 4
in
Conference Correspondent
Managing Dermatologic Toxicities
Audrey Andrews
TOP November 2015 Vol 8 No 4
in
Conference Correspondent
Managing Dermatologic Toxicities
Audrey Andrews
TON May 2015 Vol 8 No 3
in
Best Practices
Maximizing Efficacy in the Infusion Unit: Making Patients and Nurses Happy
Audrey Andrews
TON May 2015 Vol 8 No 3
in
Best Practices
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Audrey Andrews
TON - August 2013 Vol 6 No 7
in
Rare Cancers
NCCN Updates Its Clinical Practice Guidelines
Audrey Andrews
TON - July 2013 Vol 6 No 6
in
Best Practices
The Changing Oncology Landscape: Evolution or Revolution?
Audrey Andrews
TON - July 2013 Vol 6 No 6
in
Conference Correspondent
Distress Screening Should Be Integrated Into Routine Cancer Care
Audrey Andrews
TON - April 2013, Vol 6, No 3
in
Conference Correspondent
Enhancing Communication in the Advanced-Disease Setting
Audrey Andrews
TON - April 2013, Vol 6, No 3
in
Conference Correspondent
Home-Based TPN of Little Benefit in Terminally Ill Patients With GI Cancer
Audrey Andrews
,
Caroline Helwick
TON - March 2013, Vol 6, No 2
in
Supportive Care
,
Supportive Care
Evidence Lacking for Eliminating Prophylactic Platelet Transfusions
Audrey Andrews
TON - March 2013, Vol 6, No 2
in
Supportive Care
Peripheral Arterial Disease Seen With Nilotinib
Audrey Andrews
TON - March 2013, Vol 6, No 2
in
Supportive Care
Peripheral Arterial Disease Seen With Nilotinib
Audrey Andrews
TOP - February 2013 VOL 6, NO 1
in
Supportive Care
Crizotinib Is Just the Beginning
Audrey Andrews
TOP - December 2012 VOL 5, NO 8
No Increase in Leukemia or Myelodysplastic Syndrome With Adjuvant Chemotherapy for Breast Cancer
Audrey Andrews
TON - November 2012, Vol 5, No 10
in
Breast Cancer
Crizotinib Superior to Chemotherapy in First Head-to-Head Comparison
Audrey Andrews
TON - November 2012, Vol 5, No 10
in
Lung Cancer
Regional Lymph Node Irradiation Indicated for Early Breast Cancer
Audrey Andrews
TON - October 2011 Vol 4 No 7
in
Breast Cancer
Prolonged Treatment with Imatinib Recommended for High-Risk GIST
Audrey Andrews
TON - September 2011 Vol 4, No 6
in
Conference Correspondent
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Online First
in
Conference Correspondent
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Online First
in
Conference Correspondent
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Online First
in
Conference Correspondent
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Online First
in
Conference Correspondent
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Online First
in
Supportive Care
Hepatitis B Screening and Chemotherapy
Audrey Andrews
TON - June 2011, Vol 4, No 4
in
Supportive Care
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
TON - Daily
in
Prevention
Hepatitis B Screening and Chemotherapy
Audrey Andrews
TON - Daily
NCCN Updates Treatment Guidelines
Audrey Andrews
TON - March/April 2011, VOL 4, NO 2
in
Guidelines
Last modified: December 11, 2015
Home
Issues
2019
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ESMO 2018
ESMO 2018 Wrap-Up
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines
